{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2012"],"condition":["Colorectal cancer metastatic","Metastatisk colorectal cancer med metastaser isoleret til leveren.","Metastatic colorectal cancer with metastasis confined to the liver"],"disease":["Metastatic Colorectal Cancer With Metastasis Confined To The Liver","Colorectal Cancer Metastatic","Metastatisk Colorectal Cancer Med Metastaser Isoleret Til Leveren."],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2530694"],"location":["Denmark"],"study_start_month":["7"],"keyword":["Irinotecan"],"repository":["ECRIN MDR"],"study_status":["Terminated"],"additional_accession":[]},"is_claimable":false,"name":"Regional Chemotherapy with Intrahepatic Irinotecan Beads for patients with Livermetastatic Colorectal Cancer.","description":"Primary objectives: To investigate the effect of drug eluting bead with irinotecan-trans arteriel chemoembolizatin, administered in combination with FOLFOX and bevacizumab, followed by standard treatment with FLIRI and bevacizumab in patients with liver-only metastatic CRC .\nPrimary endpoints: Frequency of surgical resection and / or RFA treatment.","dates":{"creation":"2012-07-15"},"accession":"2530694","cross_references":{"EU Clinical Trials Register":["2012-000987-11"]}}